Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model

Probiotics have been widely used to prevent primary Clostridioides difficile infection (pCDI); however, there are fewer studies on their therapeutic aspects for pCDI. In this study, high doses of Bifidobacterium breve YH68 were used alone or in combination with vancomycin (VAN) and metronidazole (MT...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingpeng, Meng, Lingtong, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045379/
https://www.ncbi.nlm.nih.gov/pubmed/35311540
http://dx.doi.org/10.1128/spectrum.00672-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045379/
https://www.ncbi.nlm.nih.gov/pubmed/35311540
http://dx.doi.org/10.1128/spectrum.00672-22

Ejemplares similares